C Elizabeth Caldon

10PUBLICATIONS
81CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsChemical engineering designWastewater treatment processesCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 11, 2026
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling.

|Sep 22, 2025
Unmatched Cell Line Collections Are Not Optimal for Identification of PARP Inhibitor Response and Drug Synergies.

Zoe Phan, Kristine J Fernandez, C Elizabeth Caldon

|Dec 01, 2024
SAM-DNMT3A, a strategy for induction of genome-wide DNA methylation, identifies DNA methylation as a vulnerability in ER-positive breast cancers.

Mahnaz Hosseinpour, Xinqi Xi, Ling Liu

|Jan 05, 2024
The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.

Joanna Achinger-Kawecka, Clare Stirzaker, Neil Portman

|Jun 24, 2022
MCC Gene Silencing Is a CpG Island Methylator Phenotype-Associated Factor That Predisposes Colon Cancer Cells to Irinotecan and Olaparib.

Zeenat Jahan, Fahad A Benthani, Nicola Currey

|Sep 29, 2021
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status.

Kendelle J Murphy, Daniel A Reed, Claire Vennin

Pageof 2

Frequent Collaborators

4 joint publications

Sarah Alexandrou

3 joint publications

Elgene Lim

2 joint publications

Janett Stoehr

2 joint publications

C Marcelo Sergio